FY2030 Earnings Estimate for Aemetis Issued By HC Wainwright

Key Points

• HC Wainwright raised its FY2030 EPS forecast for Aemetis to $3.46 from $3.10; analysts expect a loss of $0.89 per share for the current full year.
• Aemetis beat Q3 expectations, reporting a $0.02-per-share loss versus the expected $0.20 loss and $88.15 million in revenue versus $74.20 million expected. Revenue rose 49% year over year, and the company reported $5.2 million in net income.
• The company cited growth in renewable natural gas, with sales volume up 39% year over year, and said its MVR project could contribute $32 million in annual cash flow in 2027. Analysts’ average rating is Hold, with an average price target of $11.88.

Aemetis, Inc (NASDAQ:AMTX - Free Report) - HC Wainwright increased their FY2030 earnings per share estimates for shares of Aemetis in a report issued on Friday, November 6th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings of $3.46 per share for the year, up from their previous forecast of $3.10. The consensus estimate for Aemetis' current full-year earnings is ($0.89) per share.

Aemetis (NASDAQ:AMTX - Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The specialty chemicals company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.18. The company had revenue of $88.15 million for the quarter, compared to analysts' expectations of $74.20 million.

AMTX has been the subject of several other research reports. Wall Street Zen upgraded Aemetis from a "sell" rating to a "hold" rating in a research note on Saturday, August 22nd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Aemetis in a report on Thursday, October 15th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $11.88.

Aemetis Stock Performance

Shares of AMTX stock opened at $1.62 on Monday. The business's 50 day moving average is $1.66 and its two-hundred day moving average is $1.94. Aemetis has a twelve month low of $1.11 and a twelve month high of $3.80. The company has a market capitalization of $116.92 million, a P/E ratio of -2.89 and a beta of 1.87.

Institutional Trading of Aemetis

A number of institutional investors have recently added to or reduced their stakes in AMTX. Russell Investments Group Ltd. increased its holdings in Aemetis by 458.6% in the third quarter. Russell Investments Group Ltd. now owns 434,404 shares of the specialty chemicals company's stock valued at $773,000 after buying an additional 356,636 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Aemetis during the 2nd quarter valued at approximately $283,000. State of Wyoming purchased a new stake in shares of Aemetis during the 3rd quarter worth approximately $226,000. Renaissance Technologies LLC purchased a new stake in shares of Aemetis during the 1st quarter worth approximately $272,000. Finally, Bank of America Corp DE boosted its stake in shares of Aemetis by 148.3% during the 1st quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company's stock worth $324,000 after acquiring an additional 60,611 shares in the last quarter. Hedge funds and other institutional investors own 27.02% of the company's stock.

More Aemetis News

Here are the key news stories impacting Aemetis this week:

• Positive Sentiment: Q3 revenue rose 49% year over year to $88.2 million. Aemetis reported $5.2 million in net income, $20.9 million in operating income and $24.8 million in adjusted EBITDA. The company’s reported loss of $0.02 per share also beat the $0.20 loss analysts expected. Aemetis Q3 financial results
• Positive Sentiment: Aemetis said Section 45Z production tax credit income was $24.7 million for the quarter, including an approximately $11 million cumulative adjustment after an updated federal emissions model. A separate report says the company expects its MVR project to contribute $32 million in annual cash flow in 2027 as 45Z values reset higher, supporting its future cash-flow outlook. MVR and 45Z outlook
• Positive Sentiment: Biogas RNG sales volume increased 39% year over year to 158,200 MMBtu, and two new dairy digesters began operating in October, expanding the network to 14 digesters serving 17 dairies. Aemetis Q3 financial results
• Neutral Sentiment: Despite the earnings beat and improved outlook, AMTX is trading lower. The available reports offer no clear explanation for the share-price weakness, so investors may be weighing execution and the timing of future project cash flows against the strong quarterly results.

About Aemetis

Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.

The company's California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.